IGF::OT::IGF PRODUCTION OF 650 BOTTLES OF TETRAHYDROURIDINE POWDER, HHSN261201200009I/HHSN26100009, DTP-16-003, DEVELOPMENT AND MANUFACTURE OF ORAL AND TOPICAL DOSAGE FORMS, PRBPERIOD OF PERFORMANCE
$66,927N02FY2016CANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
The Contractor will fill six hundred (600) containers with three grams (3g) of Tetrahydrouridine (THU) powder into each suitable size screw cap HDPE container, label (the label should be developed by consultation with COR) them, and conduct weight variation and chemical ID tests as QC release .The product will then be sent to the Clinical repository and Shelf life Contractor.
View original record on NIH RePORTER →